Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aquestive Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aquestive Therapeutics Inc
Rating: 1.59241675
Author: Trendlyne DVM scores

about

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

3.85 -0.05 (-1.28%)

33.62% Fall from 52W High

2.3M

XNAS Volume

XNAS 27 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.2 / 100

Technically Neutral

57.5 / 100

1Yr Price target upside is 119%

9 analysts

Aquestive Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aquestive Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

33.62% Fall from 52W High

SWOT Analysis

Aquestive Therapeutics Inc Live Price Chart